Y
Yasumasa Nishito
Researcher at Institute of Medical Science
Publications - 40
Citations - 5278
Yasumasa Nishito is an academic researcher from Institute of Medical Science. The author has contributed to research in topics: Medicine & Glucose uptake. The author has an hindex of 18, co-authored 33 publications receiving 4424 citations.
Papers
More filters
Journal ArticleDOI
Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice
Masaaki Komatsu,Satoshi Waguri,Masato Koike,Yu-shin Sou,Yu-shin Sou,Takashi Ueno,Taichi Hara,Noboru Mizushima,Junichi Iwata,Junichi Iwata,Junji Ezaki,Shigeo Murata,Jun Hamazaki,Yasumasa Nishito,Shun-ichiro Iemura,Tohru Natsume,Toru Yanagawa,Junya Uwayama,Eiji Warabi,Hiroshi Yoshida,Tetsuro Ishii,Akira Kobayashi,Masayuki Yamamoto,Zhenyu Yue,Yasuo Uchiyama,Eiki Kominami,Keiji Tanaka +26 more
TL;DR: The findings highlight the unexpected role of homeostatic level of p62, which is regulated by autophagy, in controlling intracellular inclusion body formation, and indicate that the pathologic process associated with autophagic deficiency is cell-type specific.
Journal ArticleDOI
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
Masaaki Komatsu,Hirofumi Kurokawa,Satoshi Waguri,Keiko Taguchi,Akira Kobayashi,Yoshinobu Ichimura,Yoshinobu Ichimura,Yu-shin Sou,Yu-shin Sou,Izumi Ueno,Ayako Sakamoto,Kit I. Tong,Mihee Kim,Yasumasa Nishito,Shun-ichiro Iemura,Tohru Natsume,Takashi Ueno,Eiki Kominami,Hozumi Motohashi,Keiji Tanaka,Masayuki Yamamoto +20 more
TL;DR: The findings indicate that the pathological process associated with p62 accumulation results in hyperactivation of Nrf2 and delineates unexpected roles of selective autophagy in controlling the transcription of cellular defence enzyme genes.
Journal ArticleDOI
Rif1 regulates the replication timing domains on the human genome
TL;DR: It is shown that Rif1 (Rap1‐interacting‐factor‐1), originally identified as a telomere‐binding factor in yeast, is a critical determinant of the replication timing programme in human cells.
Journal ArticleDOI
p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming.
Tetsuya Saito,Yoshinobu Ichimura,Yoshinobu Ichimura,Keiko Taguchi,Takafumi Suzuki,Tsunehiro Mizushima,Kenji Takagi,Yuki Hirose,Masayuki Nagahashi,Tetsuro Iso,Toshiaki Fukutomi,Maki Ohishi,Keiko Endo,Takefumi Uemura,Yasumasa Nishito,Shujiro Okuda,Miki Obata,Tsuguka Kouno,Riyo Imamura,Yukio Tada,Rika Obata,Daisuke Yasuda,Kyoko Takahashi,Tsutomu Fujimura,Jingbo Pi,Myung-Shik Lee,Takashi Ueno,Tomoyuki Ohe,Tadahiko Mashino,Toshifumi Wakai,Hirotatsu Kojima,Takayoshi Okabe,Tetsuo Nagano,Hozumi Motohashi,Satoshi Waguri,Tomoyoshi Soga,Masayuki Yamamoto,Keiji Tanaka,Masaaki Komatsu +38 more
TL;DR: In this article, the authors reveal the molecular mechanism of p62/Sqstm1-dependent malignant progression, and suggest that molecular targeting of P62/sqstmm1 represents a potential chemotherapeutic approach against hepatocellular carcinoma (HCC).
Journal ArticleDOI
PNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis.
Tetsuya Hirabayashi,Tatsuki Anjo,Tatsuki Anjo,Arisa Kaneko,Arisa Kaneko,Yuuya Senoo,Akitaka Shibata,Hiroyuki Takama,Kohei Yokoyama,Yasumasa Nishito,Tomio Ono,Choji Taya,Kazuaki Muramatsu,Kiyoko Fukami,Agustí Muñoz-Garcia,Alan R. Brash,Kazutaka Ikeda,Makoto Arita,Masashi Akiyama,Makoto Murakami,Makoto Murakami +20 more
TL;DR: It is shown that PNPLA1, an enzyme expressed in differentiated keratinocytes, plays a crucial role in the biosynthesis of ω-O-acylceramide, a lipid component essential for skin barrier and may contribute to novel therapeutic strategies for treatment of epidermal barrier defects.